Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-07 · accession 0001649094-24-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | 2024-06-07 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $70.97 | -335 | 30.8K | -1% | -$23.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-07 | F | D | 335 | $70.97 | 30,826 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. |